JohnChasKraussMD

PubMed

• 15 citations
  Is the problem list in the eye of the beholder? An exploration of consistency across physicians
  John C. Krauss, Philip S. Boonstra, Anna V. Vantsevich, Charles P. Friedman> ;Journal of the American Medical Informatics Association. 2016 Sep 1
• 2 citations
  Data Sharing to Support the Cancer Journey in the Digital Era
  John C. Krauss, Jeremy L. Warner, Suzanne E. Maddux, Jeffrey R. Brown, Richard Moldwin, Anna E. Schorer, Kevin S. Hughes, Edward P. Ambinder> ;Journal of Oncology Practice. 2016 Jan 12
• Development, implementation, and initial evaluation of a foundational open interoperability standard for oncology treatment planning and summarization.
  Warner JL, Maddux SE, Hughes KS, Krauss JC, Yu PP, Shulman LN, Mayer DK, Hogarth M, Shafarman M, Stover Fiscalini A, Esserman L, Alschuler L, Koromia GA, Gonzaga Z, Am...> ;J Am Med Inform Assoc. 2015-05-01
• 9 citations
  Successful treatment of refractory low grade duodenal lymphoma with rituximab, an anti-CD20 monoclonal antibody.
  Aman Singh, John C. Krauss, Tracey Wentz, Naresh T. Gunaratnam> ;American Journal of Clinical Oncology. 2003 Aug 1
• 14 citations
  2-Mercaptoethanol Treatment Improves Measurement of an IgMκ M-Protein by Capillary Electrophoresis
  David F. Keren, Ronald Gulbranson, John L. Carey, John C. Krauss> ;Clinical Chemistry. 2001 Jul 1
• 10 citations
  MR of myelomatous meningitis.
  Douglas J. Quint, Richard A. Levy, John C. Krauss> ;AJNR. American Journal of Neuroradiology. 1995 Jun 1
• Concurrent induction of CD4+ and CD8+ T cells during tumor growth with antitumor reactivity in adoptive immunotherapy.
  Arca, M. J., Krauss, J. C., Aruga, A., Cameron, M. J., Chang, A. E.> ;J Immunother. 1997 Mar
• Hematopoietic stem cell gene replacement therapy.
  Krauss, J. C.> ;Biochim Biophys Acta. 1992 Dec 16
• Long-term in vivo cell surface expression of human CD18 in murine hematopoietic cells.
  Krauss, J. C., Mayo-Bond, L., Rogers, C. E., Weber, K. L., Todd, R. F., Wilson, J. M.> ;Trans Assoc Am Physicians. 1991
• Expression of retroviral transduced human CD18 in murine cells: an in vitro model of gene therapy for leukocyte adhesion deficiency.
  Krauss, J. C., Bond, L. M., Todd, R. F., Wilson, J. M.> ;Hum Gene Ther. 1991
• An in vivo animal model of gene therapy for leukocyte adhesion deficiency.
  Krauss, J. C., Mayo-Bond, L. A., Rogers, C. E., Weber, K. L., Todd, R. F., Wilson, J. M.> ;J Clin Invest. 1991 Oct
• Complementation of genetic and functional defects in CD18-deficient lymphocytes by retrovirus-mediated gene transfer.
  Krauss, J. C., Ping, A. J., Mayo-Bond, L., Rogers, C. E., Anderson, D. C., Todd, R. F., Wilson, J. M.> ;Trans Assoc Am Physicians. 1990
• Reconstitution of antibody-dependent phagocytosis in fibroblasts expressing Fc gamma receptor IIIB and the complement receptor type 3.
  Krauss, J. C., PooH, Xue, W., Mayo-Bond, L., Todd, R. F., Petty, H. R.> ;J Immunol. 1994 Aug 15
• Strategies of lymphocyte activation for the adoptive immunotherapy of metastatic cancer: a review.
  Strome, S. E., Krauss, J. C., Chang, A. E., Shu, S.> ;J Hematother. 1993
• Therapeutic efficacy of T cells derived from lymph nodes draining a poorly immunogenic tumor transduced to secrete granulocyte-macrophage colony-stimulating factor.
  Arca, M. J., Krauss, J. C., Aruga, A., Cameron, M. J., Shu, S., Chang, A. E.> ;Cancer Gene Ther. 1996 Jan 01
• Cytokines as an adjuvant to tumor vaccines: efficacy of local methods of delivery.
  Kurane, S., Arca, M. T., Aruga, A., Krinock, R. A., Krauss, J. C., Chang, A. E.> ;Ann Surg Oncol. 1997 Oct 01
• Expression of major histocompatibility complex antigens in squamous cell carcinomas of the head and neck: effects of interferon gene transfer.
  Arosarena, O. A., Baranwal, S., Strome, S., Wolf, G. T., Krauss, J. C., Bradford, C. R., Carey, T. E.> ;Otolaryngol Head Neck Surg. 1999 May
• Immunobiologic effects of cytokine gene transfer of the B16-BL6 melanoma.
  Strome, S. E., Krauss, J. C., Cameron, M. J., Forslund, K., Shu, S., Chang, A. E.> ;Arch Otolaryngol Head Neck Surg. 1993 Dec
• Retroviral-mediated gene transfer in human bone marrow cells growth in continuous perfusion culture vessels.
  Eipers, P. G., Krauss, J. C., Palsson, B. O., Emerson, S. G., Todd, R. F., Clarke, M. F.> ;Blood. 1995 Nov 15
• Secretion of both IL-2 and IL-4 by tumor cells results in rejection and immunity.
  Strome, S. E., Chang, A. E., Shu, S., Krauss, J. C.> ;J Immunother Emphasis Tumor Immunol. 1996 Jan
• Diverse manifestations of tumorigenicity and immunogenicity displayed by the poorly immunogenic B16-BL6 melanoma transduced with cytokine genes.
  Arca, M. J., Krauss, J. C., Strome, S. E., Cameron, M. J., Chang, A. E.> ;Cancer Immunol Immunother. 1996 May
• Enhancement of immune reactivity in the lymph nodes draining a murine melanoma engineered to elaborate interleukin-4.
  Krauss, J. C., Strome, S. E., Chang, A. E., Shu, S.> ;J Immunother Emphasis Tumor Immunol. 1994 Aug
• Tubulogenesis from isolated single cells of adult mammalian kidney: clonal analysis with a recombinant retrovirus.
  Humes, H. D., Krauss, J. C., Cieslinski, D. A., Funke, A. J.> ;Am J Physiol. 1996 Jul
• Lack of plasminogen activator inhibitor-1 effect in a transgenic mouse model of metastatic melanoma.
  Eitzman, D. T., Krauss, J. C., Shen, T., Cui, J., Ginsburg> ;Blood. 1996 Jun 1
• Efficient transduction of early passage human melanoma to secrete IL-4.
  Krauss, J. C., Cameron, M. J., Park, A. N., Forslund, K., Chang, A. E.> ;J Immunol Methods. 1995 Jun 28
• Join now to see all